Marchf11tm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Marchf11tm1(KOMP)Wtsi |
Name: |
membrane associated ring-CH-type finger 11; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4419894 |
Gene: |
Marchf11 Location: Chr15:26309134-26409662 bp, + strand Genetic Position: Chr15, 9.77 cM
|
IMPC: |
Marchf11 gene page |
|
Mutant Cell Lines: |
EPD0415_1_C09, EPD0415_1_F09, EPD0415_1_F10, EPD0415_1_H11 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 269 starting at position 26310992 and ending at position 26311261 of Chromosome 15 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Marchf11 Mutation: |
22 strains or lines available
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|